EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Ecografía portátil de mano como alternativa accesible en países con recursos limitados

Cristina Chediak, Adela Anguisaca, Meri Magoli Orna, Belen Larco, Mayra Oñate, Juan Santacruz

Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante · 2025

DOI: 10.56867/121 ↗
AbstractBibliografische Angaben

Abstract

Background: Percutaneous native kidney biopsy (PNKB) is crucial for diagnosing renal pathology. In resource-limited environments, handheld ultrasound devices may offer a cost-effective alternative for procedural guidance. We aimed to compare the safety and diagnostic yield of PNKB performed with handheld versus high-end ultrasound systems. Methods: retrospective cohort study at Calderón General Teaching Hospital (2021–2023), including adult patients undergoing ultrasound-guided PNKB. Procedures were categorized by device: handheld (Butterfly iQ with iPhone) versus high-end (Philips Sparq). We collected data on demographics, biopsy indications, number of passes, glomerular yield, histological diagnosis, and complications. Diagnostic adequacy and safety outcomes were compared using chi-square and t-tests. Results: A total of 57 PNKBs were analyzed (22 handheld; 35 high-end). Patients were 56% female, with a mean age of 33.8 ± 12.7 years. The average number of glomeruli obtained per core was 15.7 ± 8.1. Overall, 82.5% of procedures were free of complications; 17.5% had minor complications (pain ≥12 h, hematoma, or macroscopic hematuria), and no major complications occurred. Complication-free rates were similar between groups (handheld: 72.7% vs. high-end: 88.6%; p = 0.39). Diagnostic adequacy was achieved in 85.7% of biopsies, with no significant difference between handheld (81.8%) and high-end (88.2%; p = 0.50). Conclusion: Handheld ultrasound-guided PNKB demonstrates comparable safety and diagnostic yield to high-end systems, offering a low-cost and effective alternative in resource-limited settings. Wider adoption may enhance access to renal biopsy without compromising quality or safety.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →